Key result
Transcatheter LAA occlusion devices offer practical alternatives for patients contraindicated for OAC.
Why the study?
Percutaneous transcatheter LAA closure devices are used for stroke prevention in high-risk patients with contraindications to long-term oral anticoagulation, warranting a review of their practical aspects.
This review discusses the practical aspects of four percutaneous transcatheter LAA occlusion devices (Watchman, Amulet, WaveCrest, and LAmbre) for stroke prevention.
May support LAA closure in OAC-contraindicated patients; leaves open prospective device comparisons.
Closure of the left atrial appendage (LAA) using percutaneous transcatheter occlusion devices is used for stroke prevention as an alternative for patients with a high risk and contraindications for long-term oral anticoagulation use. In this manuscript, we will discuss the practical aspects of four among the available devices that provide percutaneous intravascular closure of the LAA: Watchman, Amulet, WaveCrest, and LAmbre.
No takes yet. Share an insight, caveat, or question.
Gianni et al. (2020) conducted a review in High risk for stroke with contraindications for long-term oral anticoagulation. Percutaneous transcatheter occlusion devices (Watchman, Amulet, WaveCrest, LAmbre) was evaluated. Percutaneous transcatheter occlusion devices, including Watchman, Amulet, WaveCrest, and LAmbre, provide practical alternatives for left atrial appendage closure in patients contraindicated for oral anticoagulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: